Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Mdaw94on Apr 24, 2019 7:05pm
95 Views
Post# 29666817

RE:RE:RE:RE:RE:RE:RE:RE:May 14th earnings

RE:RE:RE:RE:RE:RE:RE:RE:May 14th earnings
Homestretch4me wrote: You dont get it. Did your parents have to sign a waiver allowing you to actually trade in the stock market? You seem to be mentally challenged. Canopy has almost twice the sales Aurora in Canada and that happened without the constellation money. We have more capacity than Aurora currently which also happened without the constellation deal and without issuing a billion shares. The only thing Aurora has that's better than canopy currently are pseudo medical sales and I use the term pseudo because those medical sales are going to come to an end when canopy starts to receive DIN numbers. You paid 3.2 billion dollars to beat us in medical sales by what? 10 million.....that will take Aurora a while to recoup that money. Remind me which hemp industrial park that Aurora was selected for.........that's right none. Chuck Schumer, Jeff Beumer, Snoop Dogg, Martha Stewart, Seth Rogen tell me which of these people are partnered with Aurora, that's right none. Which company has the largest guaranteed contracts with the provinces, you guessed it canopy growth. So you spent 3.2 billion to get cannimed and you have half our sales. How much you think acreage Holdings is going to add to canopy's bottom line when States Act is enacted and canopy can hit the ground running in the US? I'll answer that for you. It's going to hit canopies bottom-line a hell of a lot more than cannimed did for Aurora. I should have just given you the short answer. Canopy has done everything bigger and better than Aurora and will continue to do so because their management team is heads and tails above your wait and be amazed management team. You guys are in a cash crunch and are going to have to raise money again soon which means more dilution. You never know though maybe Nelson Putz to find a company that doesn't do good due diligence that would partner with you guys. Good luck with that
bionicjoe wrote:
Homestretch4me wrote: $60 is a chronic crack pipe example. $20 is a regular crack pipe example. A $20 price on your stock would give you almost the same valuation as canopy with half the sales, no us footprint and a management team that pales in comparison to canopies. Your management team cannot deliver and that's why you have no deal. The used shares like Monopoly money early on in the game to try and become the market leader. It failed miserably. Aurora is a distant second to canopy and may not hold on to Second Place much longer when some of the mso's in the US get a little more traction. Just say no........... To crack.
bionicjoe wrote:
Homestretch4me wrote: $60 share price??? Are you smoking the crack pipe? Do you not know that Aurora has over a billion shares outstanding and a $60 share price would give you a market cap North of 60 billion dollars, triple that of canopy with half the sales of canopy. Put down the crack pipe my friend and stop investing when you're high. Oh my God the people on this board keep getting dumber and dumber
bionicjoe wrote: Those figures are nice but without a major partner(s) Aurora will be fighting the fight to gain market sentiment with 1 arm tied behind it's back. The long shareholder is not here to see a $14 or $15 sp but one in the $20s and climbing It's commendable that management has chosen to maintain control of the company by not selling out to a large multinational but until investors see tangible progress on the partnership front the market will still have doubts if they can get it done. I'm sure investors would be willing to trade off selling 50% of the company like Canopy did if it means a $60 sp. Let's hope this multi-partner concept works because it's our money on the line.

 


Don't get excited or we'll have to call your mother to come get you. The $60 bucks was just an example. No reason to get your shorts in a knot. I'm sure you caught the drift of my post. To get the sp results Canopy shareholders are enjoying there must a partnership deal(s) with a big established multinational. You can have all the good analyst reviews you want but without a consummated deal Aurora won't be seen by investors as whole. We have now attracted the penny day traders who are ready to ditch the stock at a moment's notice while Canopy gathers in serious investors with dollars to spend to keep driving up its sp. Cam Battley is a great promotor but his story of wait and be amazed is getting old even with shareholders, nevermind the market.

 


LOL, what has Canopy done bigger and better than Aurora that isn't the result of the Constellation Brands deal? If it wasn't for the cash transfusion received by selling 50% of itself in that deal Canopy's share count now would be a billion also. Maybe Canopy got lucky because since then no other multinational has jumped in to the degree Constellation has.
 




As usual ether you just lie on purpose or you don’t know. Canimed was purchased for just over 800 million for its oils and jell pills . It was a steal. Capable of producing 1.5 billion in sales alone. Look it up. Medleaf was purchased for 2 billion not 3.2 look it up. Aurora has largest capacity with highest quality EU GMP look it up. Read any analyst covering this sector. Aurora produced more kgs the Canopy in the first legal Q. Read the ERs. Canopy had stock piled weed for months even over a year before oct 17. That’s how they had more sales that Q. It’s all out there public knowledge. Look it up . They are two different companies talking different routes for there respective end games. Your starting to sound nervous with all your ACB bashing

Bullboard Posts